Validation of a Nutrition Screening Tool

Ovarian Cancer Clinical Trial

Official title:

The Validation of Two Inpatient Adult Nutrition Screening Tools in Cancer Care - a Prospective Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01851928
• Other study ID #: CCR 3621
• Status: Completed
• Phase: N/A
• First received: April 20, 2012
• Last updated: May 8, 2013
• Start date: July 2011
• Est. completion date: March 2013

Study information

• Verified date: May 2013
• Source: Royal Marsden NHS Foundation Trust
• Contact: n/a
• Is FDA regulated: No
• Health authority: United Kingdom: Research Ethics Committee
• Study type: Observational

Clinical Trial Summary

The objective of this study is to evaluate the sensitivity and specificity of two nutrition screening tools to identify inpatients with malnutrition or at risk of malnutrition. The two tools are the Royal Marsden Abridged Adult Nutrition Screening Tool (AANST) and the Malnutrition Screening Tool (MST)[10] The tools will be compared with the currently accepted gold standard, Patient Generated Subjective Global Assessment (PG-SGA). Both screening tools are in the form of scored questionnaires and are suitable for electronic input.

The ultimate objective is to select an adult inpatient nutrition screening tool with the highest sensitivity for future use in the oncology inpatient setting in order to allow prompt commencement of an appropriate nutrition care plan.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 128
• Est. completion date: March 2013
• Est. primary completion date: September 2012
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

• All adult inpatients, over the age of 18, admitted to RMH for whom a measured weight and height can be obtained

Exclusion Criteria

• Patients for whom it is not possible to obtain a measured height and weight

• People with a definitive diagnosis of dementia

• People who lack capacity to understand the purpose of the study and to consent

• Patients who are unable to understand and speak English

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Adenocarcinoma
• Adenocarcinoma of the Gastroesophageal Junction
• Cervical Cancer
• Endometrial Cancer
• Esophageal Cancer
• Esophageal Neoplasms
• Fallopian Tube Cancer
• Gastric Cancer
• Ovarian Cancer
• Sarcoma
• Uterine Cervical Neoplasms
• Vaginal Cancer
• Vaginal Neoplasms
• Vulvar Cancer
• Vulvar Neoplasms

Locations

Country	Name	City	State
United Kingdom	Royal Marsden Hospital NHS Foundation Trust	London	London ..

Sponsors (1)

Lead Sponsor	Collaborator
Royal Marsden NHS Foundation Trust

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sensitivity of Screening Tool	The primary endpoint of the study is the sensitivity of each screening tool as compared to the gold standard of PG-SGA when completed by a trained dietitian.	24 hrs	No
Secondary	Specificity of the Tool	Secondary endpoints are as follows: specificity of the screening tool; proportion of inpatients with malnutrition on admission	24 hrs	No